Classification of
H1 figures: Emerald Stay divestment with positive P&L impact Topic: 029 published H1 2024 figures which were marked by the positive contributions from the successful divestment of Emerald Stay, but also the further positive developments of the group’s key holding, In H1, the group’s net income stood at € 0.7m, comparing to previous year’s € 0.4m loss. Besides lower other operating expenses (from € 0.32m to € 0.18m), this was carried by a € 0.94m other operating income related to the divestment of Emerald Stay in February. As a reminder, 029 sold it's 5.2% stake in Emerald Stay. The transaction is expected to generate roughly € 1.6m gross proceeds, reflecting a realized multiple on the FY23 book value of around 2.3x and 2.7x on the invested capital. What’s more, Limestone spearheaded a € 40m Series A financing round for Changes in management board. On Current portfolio overview. Besides Limestone, the group’s portfolio also comprises TRIP Drinks (10.1% of NAV, eNuW), UK’s leading CBD oils and drinks brand, which is progressing with its geographic expansion, hotelbird (3.9% of NAV, eNuW), Brother’s Bond (1.5% of NAV, eNuW) and fjör (0.3% of NAV, eNuW), which are all showing operational developments in line with expectations. 029 Group remains a HOLD with an unchanged € 14 PT based on a sum-of- he-parts valuation with a 5% holding discount. You can download the research here: http://www.more-ir.de/d/30997.pdf For additional information visit our website: www.nuways-ag.com/research Contact for questions: Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 ++++++++++ Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, |
2003687 08.10.2024 CET/CEST